June 15, 2020 / 12:06 PM / 21 days ago

BRIEF-Aldeyra Receives Orphan Medicinal Product Designation From European Commission For ADX-2191 Retinal Disease Program

June 15 (Reuters) - Aldeyra Therapeutics Inc:

* ALDEYRA THERAPEUTICS RECEIVES ORPHAN MEDICINAL PRODUCT DESIGNATION FROM EUROPEAN COMMISSION FOR ADX-2191 RETINAL DISEASE PROGRAM Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below